Unlisted
| Company Name | 주식회사 클라시아 |
| Business Reg. No. | 1308647315 |
| CEO | 안현아 |
| Address | 서울 강서구 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Main Products | 연구용역,의학및약학개발업,무역,주거용 건물 임대업,비주거용 건물 임대업(점포, 자기땅),데이터베이스제작 및 검색서비스사업,온라인 정보 제공업,매니저업, |
| Established | Contact |
| Phone | 2858**** |
| Website | Contact |
| Regular Employees | Contact |
| Corp. Reg. No. | 121111-******* |
Venture Certified
| 기술평가보증기업(기금) | 2012-07-27 ~ 2014-07-26 | 20120106734 | 2012-07-27 |
| 기술평가보증기업(기금) | 2014-07-27 ~ 2016-07-26 | 20140107701 | 2012-07-27 |
| 기술평가보증기업(기금) | 2016-07-27 ~ 2018-07-26 | 20160109536 | 2012-07-27 |
| 기술평가보증기업(기금) | 2018-07-27 ~ 2020-07-26 | 20180110245 | 2012-07-27 |
| 기술평가보증기업(기금) | 2020-07-27 ~ 2022-07-26 | 20200110793 | 2012-07-27 |
| 연구개발유형 | 2022-07-27 ~ 2025-07-26 | 20220921020006 | 2012-07-27 |
| 연구개발유형 | 2025-07-27 ~ 2028-07-26 | 20250909020013 | 2012-07-27 |
Revenue CAGR +9.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 40.2B | 39.1B | 33.4B |
| Operating Profit | 15.7B | 10.2B | 5.7B |
| Net Profit | 17.0B | 11.0B | 6.2B |
| Total Assets | 78.6B | 62.7B | 54.3B |
| Total Liabilities | 25.2B | 24.8B | 26.9B |
| Total Equity | 53.4B | 38.0B | 27.4B |
▲ 10.8%
▲ 97.9%
▲ 81.5%
▼ 42.1%
▲ 22.8%
| Name | Position | Role |
|---|---|---|
| 안현아 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울 강서구",
"ceo_name": "안현아",
"certificate": [
{
"cert_number": "20120106734",
"changes": "",
"disclosure_date": "2012-07-27",
"first_cert_date": "2012-07-27",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-07-27 ~ 2014-07-26"
},
{
"cert_number": "20140107701",
"changes": "",
"disclosure_date": "2014-06-26",
"first_cert_date": "2012-07-27",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-07-27 ~ 2016-07-26"
},
{
"cert_number": "20160109536",
"changes": "",
"disclosure_date": "2016-08-17",
"first_cert_date": "2012-07-27",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2016-07-27 ~ 2018-07-26"
},
{
"cert_number": "20180110245",
"changes": "",
"disclosure_date": "2018-08-27",
"first_cert_date": "2012-07-27",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-07-27 ~ 2020-07-26"
},
{
"cert_number": "20200110793",
"changes": "",
"disclosure_date": "2020-08-18",
"first_cert_date": "2012-07-27",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-07-27 ~ 2022-07-26"
},
{
"cert_number": "20220921020006",
"changes": "",
"disclosure_date": "2022-09-21",
"first_cert_date": "2012-07-27",
"no": "6",
"type": "연구개발유형",
"valid_period": "2022-07-27 ~ 2025-07-26"
},
{
"cert_number": "20250909020013",
"changes": "대표자",
"disclosure_date": "2025-09-09",
"first_cert_date": "2012-07-27",
"no": "7",
"type": "연구개발유형",
"valid_period": "2025-07-27 ~ 2028-07-26"
}
],
"company_name": "주식회사 클라시아",
"corp_no": "121111-*******",
"financials": {
"2022": {
"capital_stock": 500000000,
"cost_of_sales": 794038000,
"current_assets": 3363182000,
"current_liabilities": 1132228000,
"gross_profit": 2548194000,
"net_income": 623499000,
"net_income_bs": 605189000,
"non_current_assets": 2063088000,
"non_current_liabilities": 1556153000,
"non_operating_expenses": 71024000,
"non_operating_income": 126897000,
"operating_profit": 567626000,
"revenue": 3342232000,
"sga_expenses": 1980568000,
"total_assets": 5426270000,
"total_equity": 2737889000,
"total_liabilities": 2688381000
},
"2023": {
"capital_stock": 500000000,
"cost_of_sales": 672157000,
"current_assets": 3956340000,
"current_liabilities": 804023000,
"gross_profit": 3236898000,
"net_income": 1102141000,
"net_income_bs": 1080321000,
"non_current_assets": 2318593000,
"non_current_liabilities": 1672200000,
"non_operating_expenses": 72385000,
"non_operating_income": 154188000,
"operating_profit": 1020338000,
"revenue": 3909054000,
"sga_expenses": 2216560000,
"total_assets": 6274934000,
"total_equity": 3798711000,
"total_liabilities": 2476223000
},
"2024": {
"capital_stock": 500000000,
"cost_of_sales": 100850000,
"current_assets": 5316294000,
"current_liabilities": 833192000,
"gross_profit": 3917470000,
"net_income": 1698741000,
"net_income_bs": 1561343000,
"non_current_assets": 2548451000,
"non_current_liabilities": 1691000000,
"non_operating_expenses": 86813000,
"non_operating_income": 214263000,
"operating_profit": 1571291000,
"revenue": 4018320000,
"sga_expenses": 2346178000,
"total_assets": 7864745000,
"total_equity": 5340554000,
"total_liabilities": 2524192000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "연구용역,의학및약학개발업,무역,주거용 건물 임대업,비주거용 건물 임대업(점포, 자기땅),데이터베이스제작 및 검색서비스사업,온라인 정보 제공업,매니저업,",
"phone": "2858****",
"years": [
2024,
2023,
2022
]
}